4D Molecular Therapeutics (FDMT) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for 4D Molecular Therapeutics (FDMT) over the last 7 years, with Q3 2025 value amounting to $13.1 million.
- 4D Molecular Therapeutics' Other Gross PP&E Adjustments rose 1608.03% to $13.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year increase of 1608.03%. This contributed to the annual value of $12.4 million for FY2024, which is 3466.58% down from last year.
- According to the latest figures from Q3 2025, 4D Molecular Therapeutics' Other Gross PP&E Adjustments is $13.1 million, which was up 1608.03% from $13.6 million recorded in Q2 2025.
- 4D Molecular Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $20.4 million for Q2 2024, and its period low was $3.6 million during Q4 2021.
- In the last 5 years, 4D Molecular Therapeutics' Other Gross PP&E Adjustments had a median value of $13.3 million in 2025 and averaged $13.5 million.
- As far as peak fluctuations go, 4D Molecular Therapeutics' Other Gross PP&E Adjustments soared by 33175.09% in 2022, and later tumbled by 3567.98% in 2024.
- Over the past 5 years, 4D Molecular Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $3.6 million in 2021, then surged by 331.75% to $15.5 million in 2022, then rose by 22.49% to $18.9 million in 2023, then tumbled by 34.67% to $12.4 million in 2024, then increased by 6.13% to $13.1 million in 2025.
- Its Other Gross PP&E Adjustments stands at $13.1 million for Q3 2025, versus $13.6 million for Q2 2025 and $13.3 million for Q1 2025.